Introduction {#s1}
============

Pregnancy-associated plasma protein-a (PAPP‐A) and PAPP‐A2 belong to the conserved pappalysin proteinase family ([@bib5]; [@bib50]; [@bib17]). PAPP-A was first discovered in the plasma of pregnant women in the 1970s. Decades of studies suggest that PAPP-A and PAPP-A2 are zinc metalloproteinases cleaving insulin-like growth factor binding proteins (IGFBPs) ([@bib42]; [@bib50]; [@bib17]). IGFBPs are a family of six secreted proteins that bind IGF ligands with high affinity and regulate IGF availability to the IGF1 receptor ([@bib4]; [@bib2]; [@bib15]). In vitro studies suggested that PAPP-A is tethered to the cell-surface and primarily cleaves IGFBP4 and IGFBP5 among the six IGFBPs. PAPP-A2, on the other hand, is secreted and cleaves IGFBP3 and IGFBP5 ([@bib50]). Papp-a knockout mice showed a 40% reduction in body size ([@bib16]), a phenotype similar to those of the IGF1 and IGF2 mutant mice ([@bib3]; [@bib44]). Papp-a2 knockout mice had a modest decrease in body size ([@bib13]; [@bib14]). These findings led to the proposal that PAPP-A and PAPP-A2 promote somatic growth by increasing bioavailable IGFs ([@bib50]; [@bib25]; [@bib17]). This notion is further supported by recent clinical studies showing that human patients carrying inactivating mutations in the PAPP-A2 gene displayed progressive growth failure ([@bib20]; [@bib25]). In addition to reduced body height, these patients also had lower bone mineral density ([@bib20]; [@bib25]). Likewise, the Papp-a mutant mice had delayed appearance of ossification centers and reduced calcified bone mass ([@bib16]). The Papp-a2 mutant mice had sex-and age-specific defects in bone structure and mineral density ([@bib14]). Despite observations suggest a role of these metalloproteinases in bone mineralization, there is still a lack of causal evidence and the underlying mechanisms are poorly understood.

We have recently found that genetic deletion of IGF binding protein 5a (Igfbp5a), a major PAPP-A substrate, results in reduced calcified bone mass in zebrafish even though *igfbp5a* is not expressed in skeletal tissues ([@bib46]). In zebrafish embryos and larvae, *igfbp5a* is specifically expressed in a population of Ca^2+^-transporting epithelial cells (ionocytes) located in the yolk sac ([@bib19]; [@bib45]). These ionocytes, known as NaR cells, are functionally similar to human intestinal epithelial cells. They play a key role in maintaining body Ca^2+^ homeostasis by uptaking Ca^2+^ from the surrounding habitat, ([@bib31]; [@bib43]). A hallmark of NaR cells and human intestinal epithelial cells is the expression of Trpv6/TRPV6, a constitutive calcium channel constituting the first and rate-limiting step in the transcellular Ca^2+^ transport pathway ([@bib29]; [@bib51]; [@bib19]). Trpv6/TRPV6 also regulates NaR cell quiescence ([@bib65]). NaR cells, normally non-dividing and quiescent, rapidly exit quiescence and re-enter the cell cycle in response to low \[Ca^2+^\] stress ([@bib19]; [@bib45]). This is thought to be an adaptive response, allowing animals to take up adequate Ca^2+^ for maintaining body Ca^2+^ homeostasis and survive under low \[Ca^2+^\] conditions ([@bib46]). Interestingly, while no change was observed in NaR cells under normal \[Ca^2+^\] conditions, the lower \[Ca^2+^\] stress-induced adaptive NaR cell reactivation and proliferation were impaired in *igfbp5a*^-/-^ fish ([@bib46]). The mechanism underlying this \[Ca^2+^\]-dependent phenotype is unclear.

Zebrafish have three genes belonging to the pappalysin family, including *papp-aa*, *papp-ab*, and *papp-a2* ([@bib35]; [@bib36]; [@bib64]). In this study, we show that among the three genes, *papp-aa* is highly expressed in NaR cells. Genetic deletion of *papp-aa* but not the paralogous *papp-ab*, resulted in a lack of calcified bone and abolished low \[Ca^2+^\] stress-induced NaR cell reactivation and proliferation. We provide several lines of independent evidence showing that Papp-aa-mediated Igfbp5a proteolysis acts as a \[Ca^2+^\]-regulated switch linking local IGF signaling to epithelial cell proliferation and organismal Ca^2+^ balance.

Results {#s2}
=======

Papp-aa is highly expressed in NaR cells and is indispensable in NaR cell reactivation and bone calcification {#s2-1}
-------------------------------------------------------------------------------------------------------------

To date, published whole mount in situ hybridization data suggest that *papp-aa* mRNA is expressed in various neural tissues, *papp-ab* mRNA in developing myotomes and brain ([@bib35]; [@bib64]; [@bib49]; [@bib1]), and *papp-a2* in the notochord and brain ([@bib36]). Because NaR cells are located in the yolk sac epidermis, they are more sensitive to protease K treatment, a key step in the whole mount in situ hybridization procedure to permeabilize embryos. To test whether any of the pappalysin genes are expressed in NaR cells, we isolated NaR cells from *Tg(igfbp5a:GFP)* fish using FACS. *Tg(igfbp5a:GFP)* fish are a reporter fish line in which NaR cells are labeled by GFP expression ([@bib45]). The mRNA levels of *papp-aa* in NaR cells were 2-fold higher than those of *papp-ab* and *papp-a2* ([Figure 1A](#fig1){ref-type="fig"}). Low \[Ca^2+^\] stress treatment had no effect on their mRNA levels ([Figure 1A](#fig1){ref-type="fig"}). We also compared the *papp-aa* mRNA levels in NaR cells with those non-GFP cells from the rest of the fish body. The level of *papp-aa* mRNA in NaR cells was approximately 10-fold greater ([Figure 1B](#fig1){ref-type="fig"}). In comparison, the *papp-ab* mRNA levels were similar between NaR cells and other cells ([Figure 1C](#fig1){ref-type="fig"}). Next, whole mount in situ hybridization was performed after optimizing the permeabilization condition. In agreement with previous reports ([@bib64]), strong *papp-aa* mRNA signal was detected in the brain ([Figure 1D](#fig1){ref-type="fig"}). Meanwhile, *papp-aa* mRNA signals were detected in cells in the yolk sac region beginning at three dpf ([Figure 1D](#fig1){ref-type="fig"}). Double color label staining showed that *papp-aa* mRNA was indeed expressed in NaR cells ([Figure 1E](#fig1){ref-type="fig"}).

![Papp-aa is highly expressed in NaR cells.\
(**A**) *Tg(igfbp5a:GFP)* fish were raised in E3 embryo medium to 3 days post fertilization (dpf) and transferred to embryo media containing the indicated \[Ca^2+^\]. Eighteen hours later, NaR cells were isolated by FACS. The levels of *papp-aa*, *papp-ab*, and *papp-a2* mRNA were measured and shown. Data shown are Mean ± SEM, n = 4. (**B--C**) NaR cells and other cells in four dpf *Tg(igfbp5a:GFP)* larvae were separated by FACS. The levels of *papp-aa* (**B**) and *papp-ab* (**C**) mRNA were measured and shown. \*, p\<0.05 by unpaired two-tailed t test. n = 3. (**D**) Whole mount in situ hybridization analysis of *papp-aa* mRNA in three dpf larvae. HB, hindbrain. pLL, posterior lateral line ganglion. Arrowheads indicate *papp-aa* mRNA signal in the yolk sac region. A sense cRNA probe was used as a negative control. Scale bar = 0.2 mm. (**E**) *Tg(igfbp5a:GFP)* fish of the indicated stages were analyzed by double label staining. Scale bar = 20 µm.\
Figure 1---source data 1.Excel spreadsheet containing quantitative data for [Figure 1](#fig1){ref-type="fig"}.](elife-52322-fig1){#fig1}

Next, a blind test was carried out to investigate the possible function of Papp-aa in NaR cells. For this, progeny from *papp-aa^+/-^* fish ([@bib64]) intercrosses, which were a mixture of mutant, heterozygous, and wild type embryos, were raised in the standard E3 embryo medium until three dpf. The fish were transferred to normal or low \[Ca^2+^\] embryo rearing solutions at three dpf and sampled at five dpf ([Figure 2A](#fig2){ref-type="fig"}). NaR cells were visualized by in situ hybridization using an *igfbp5a* cRNA probe and quantified. Larvae were subsequently genotyped individually ([Figure 2A](#fig2){ref-type="fig"}). Under the normal \[Ca^2+^\] condition, NaR cell numbers between these three different genotype groups were similar ([Figure 2B and C](#fig2){ref-type="fig"}). Low \[Ca^2+^\] stress treatment, however, resulted in a 4-fold, highly significant increase in NaR cell number in the wild-type and heterozygous fish groups. This increase was abolished in *papp-aa^-/-^* mutant fish ([Figure 2B and C](#fig2){ref-type="fig"}). Similar results were obtained using *trpv6* mRNA as a NaR cell marker ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). To test whether this action is specific to Papp-aa, we deleted the paralogous *papp-ab* gene using CRISPR-Cas9. Deletion of Papp-ab had no effect on low \[Ca^2+^\] stress-induced NaR cell increase nor did it affect NaR cell number under the normal \[Ca^2+^\] condition ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}).

![Genetic deletion of *papp-aa* impairs NaR cell reactivation and bone calcification.\
(**A**) Diagram of the experimental design. Progeny of *papp-aa*^+/-^ fish intercrosses were raised in standard E3 embryo medium to three dpf. The progeny is a mixture of homo, hetero, and wild type embryos. They were transferred to the low \[Ca^2+^\] (0.001 mM) or normal \[Ca^2+^\] (0.2 mM) embryo medium at three dpf. Two days later, NaR cells in each fish were detected by *igfbp5a* mRNA expression and quantified. These fish were genotyped individually afterwards. (**B--C**) Progeny of *papp-aa^+/-^* intercrosses were treated as described in (**A**). Representative images are shown in (**B**) and quantified data in (**C**). Scale bar = 0.1 mm. n = 10 \~ 30 fish/group. In this and all subsequent figures, data shown are Mean ± SEM. Different letters indicate significant differences among groups by one-way ANOVA followed by Tukey's multiple comparison test (p\<0.05). (**D--E**) Progeny of *papp-aa^+/-^;Tg(igfbp5a:GFP)* fish intercrosses were raised in E3 medium to three dpf and transferred to the low \[Ca^2+^\] (0.001 mM) or normal \[Ca^2+^\] (0.2 mM) embryo medium. Two days later, the number of GFP-expressing NaR cells in each larva was quantified. The larvae were genotyped individually subsequently. Representative images are shown in (**D**) and quantified data in (**E**). Scale bar = 0.1 mm. n = 16 \~ 82 fish/group. (**F--G**) Fish of the indicated genotypes were raised in E3 embryo medium to 7 dpf and 12 dpf and stained with Alizarin Red. Scale bar = 0.2 mm.\
Figure 2---source data 1.Excel spreadsheet containing quantitative data for [Figure 2](#fig2){ref-type="fig"}.](elife-52322-fig2){#fig2}

Next, we examined NaR cell reactivation and proliferation using the progeny of *papp-aa^+/-^;Tg(igfbp5a:GFP)* fish intercrosses. While NaR cells in *papp-aa^+/+^;Tg(igfbp5a:GFP)* larvae and *papp-aa^+/-^;Tg(igfbp5a:GFP)* larvae divided robustly under low \[Ca^2+^\] stress, NaR cell re-activation was abolished in *papp-aa^-/-^;Tg(igfbp5a:GFP)* larvae ([Figure 2D and E](#fig2){ref-type="fig"}). This data suggest that Papp-aa plays a critical role in low \[Ca^2+^\] stress-induced NaR cell reactivation and proliferation.

To test whether the action of Papp-aa is restricted to NaR cells, we examined H^+^-ATPase-rich (HR) cells and Na^+^/Cl^-^ cotransporter (NCC) cells, two other types of ionocytes located in the yolk sac epidermis. HR and NCC cells are responsible for H^+^ secretion/Na^+^ uptake/NH^+^ excretion and Na^+^ uptake/Cl^-^ uptake, respectively ([@bib31]). Deletion of Papp-aa did not change HR or NCC cell numbers ([Figure 2---figure supplement 1B and C](#fig2s1){ref-type="fig"}).

No difference was observed between *papp-aa^-/-^* mutant fish and their siblings in terms of gross appearance, growth rate, or developmental speed ([Figure 2---figure supplement 3A--E](#fig2s3){ref-type="fig"}). We noted that NaR cells in wild-type *Tg(igfbp5a:GFP)* larvae had a narrow apical opening when kept in the normal \[Ca^2+^\] medium ([Figure 2---figure supplement 3F](#fig2s3){ref-type="fig"}). This apical opening became markedly enlarged under low \[Ca^2+^\] stress treatment ([Figure 2---figure supplement 3F](#fig2s3){ref-type="fig"}). Although the functional significance of this morphological change is unclear, this low \[Ca^2+^\] stress-induced morphological change in NaR was absent in *papp-aa^-/-^* mutant fish ([Figure 2---figure supplement 3F](#fig2s3){ref-type="fig"}). Alizarin red staining analysis indicated a complete lack of calcified bone in *papp-aa^-/-^* fish at seven dpf ([Figure 2F](#fig2){ref-type="fig"}). At 10 and 12 dpf, some components of the craniofacial skeleton in *papp-aa^-/-^* fish were calcified, albeit at very low levels ([Figure 2G](#fig2){ref-type="fig"}; [Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}). However, none of the vertebral columns in *papp-aa^-/-^* fish were stained by Alizarin red even at 10 and 12 dpf, suggesting the mutant fish suffered from Ca^2+^ deficiency ([Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}). In agreement with a previous report ([@bib64]), *papp-aa^-/-^* mutant fish died around 2 weeks when kept under normal \[Ca^2+^\]. Together, these results suggest that Papp-aa plays an indispensable role in regulating bone calcification.

Endogenous Papp-aa proteinase activity in NaR cells is critical {#s2-2}
---------------------------------------------------------------

To determine whether Papp-aa expression is sufficient in inducing NaR cell reactivation and proliferation, Papp-aa-IRES-mCherry was randomly expressed in NaR cells in *papp-aa^-/^*^-^; *Tg(igfbp5a:GFP*) fish using a Tol2 transposon and BAC-mediated genetic mosaic assay ([@bib46]). Re-introduction of Papp-aa restored low \[Ca^2+^\] stress-induced NaR cell reactivation ([Figure 3A and B](#fig3){ref-type="fig"}). Previous studies suggested that pappalysins can affect zebrafish development in both proteinase activity-dependent as well as independent manners ([@bib35]; [@bib36]). To test whether this action of Papp-aa requires its proteinase activity, a conserved glutamate residue (E501) in the active site known to be critical for human PAPP-A proteinase activity ([@bib5]) was changed to alanine. As expected, while Papp-aa cleaved Igfbp5a, Papp-aa E501A had little proteolytic activity ([Figure 3C](#fig3){ref-type="fig"}). When the E501A mutant was expressed in NaR cells in *papp-aa^-/^*^-^; *Tg(igfbp5a:GFP*) using the genetic mosaic assay, it had no effect in rescuing NaR cell reactivation ([Figure 3A and B](#fig3){ref-type="fig"}). Although the Tol2 transposon BAC-mediated genetic mosaic assay is useful in testing the sufficiency of Papp-aa and its mode of action, this approach cannot be used to rescue the lethality phenotype because it only targets the expression of Papp-aa transiently and to a small subset of NaR cells in a mosaic pattern.

![Papp-aa proteinase activity is in NaR cells critical.\
(**A--B**) Progeny of *papp-aa^+/-^;Tg(igfbp5a:GFP)* intercrosses were injected with *BAC(igfbp5a:mCherry)* containing the indicated gene. They were subjected to the low \[Ca^2+^\] stress test described in [Figure 2A](#fig2){ref-type="fig"}. Papp-aa-IRES-mCherry, Papp-aa E501A-IRES-mCherry, or mCherry expressing NaR cells were detected by GFP and mCherry expression. NaR cells expressing mCherry or Papp-aa-mCherry (yellow, double labeled by GFP and mCherry) were scored following a published scoring system ([@bib46]). Representative images are shown in (**A**) and quantified data in (**B**). Scale bar = 50 µm. +, one cell division, -, no division. \*\*\*\*, p\<0.0001 by Chi-square test. The total cell number is shown above the bar. (**C**) Conditioned media collected from HEK293 cells co-transfected with Igfbp5a and the indicated plasmid were analyzed by western blotting. Intact and cleaved Igfbp5a bands were indicated. (**D--E**) *Tg(igfbp5a:GFP)* fish were transferred to the low \[Ca^2+^\] medium containing 0--8 µM ZnCl~2~ (**D**) or 200 µM Batimastat at three dpf (**E**). After two days of treatment, NaR cells were quantified and shown. n = 18 \~ 25 fish/group. \*\*, p\<0.001 by unpaired two-tailed t test. (**F--H**) *Tg(igfbp5a:GFP)* embryos were injected with *BAC(igfbp5a:mCherry, BAC(igfbp5a:hSTC1-IRES-mCherry)* (**G**) or *BAC(igfbp5a:hSTC2-IRES-mCherry*) (**H**). They were raised and subjected to the low \[Ca^2+^\] stress test described in [Figure 2A](#fig2){ref-type="fig"}. NaR cells expressing mCherry or human STC (yellow, double labeled by GFP and mCherry) were scored following a published scoring system ([@bib46]). Representative images are shown in (**F**) and quantified results in (**G and H**). ++, two cell division, +, one cell division, -, no division during the experiment. \*\*\*\*, p\<0.0001, Chi-square test. Total cell number is shown above the bar.\
Figure 3---source data 1.Excel spreadsheet containing quantitative data for [Figure 3](#fig3){ref-type="fig"}.](elife-52322-fig3){#fig3}

To test the role of Papp-aa further, *Tg(igfbp5a:GFP)* embryos were treated with ZnCl~2~ or batimastat, two metzincin metalloproteinase inhibitors ([@bib57]). Both compounds inhibited low \[Ca^2+^\] stress-induced NaR cell proliferation ([Figure 3D and E](#fig3){ref-type="fig"}). Next, we targeted expression of human stanniocalcin (STC) 1 and 2 in NaR cells, respectively. STC2 has been shown to be able to inhibit PAPP-A activity by forming a covalent complex with PAPP-A, while STC1 inhibits PAPP-A activity by non-covalent protein-protein interaction ([@bib33]; [@bib37]). When STC1 was specifically expressed in a subset of NaR cells using the genetic mosaic assay, it inhibited low \[Ca^2+^\] stress-induced NaR cell proliferation, while mCherry expression had no such effect ([Figure 3F and G](#fig3){ref-type="fig"}). Likewise, targeted expression of STC2 also inhibited low \[Ca^2+^\] stress-induced NaR cell proliferation ([Figure 3H](#fig3){ref-type="fig"}). These results suggest that endogenous Papp-aa proteinase activity in NaR cells is required for NaR cell reactivation and proliferation in response to low \[Ca^2+^\] stress.

Papp-aa-mediated Igfbp5 proteolysis in NaR cells is critical {#s2-3}
------------------------------------------------------------

Human PAPP-A is a specific IGFBP4/5 proteinase ([@bib50]). Among the three zebrafish pappalysin family members, Papp-ab has been shown to cleave human IGFBP4 and IGFBP5 but not the other four IGFBPs ([@bib35]). Zebrafish Papp-a2 can cleave human IGFBP3 and IGFBP5, but not other IGFBPs ([@bib36]). The substrate specificity of zebrafish Papp-aa has not been reported. We therefore performed an in vitro proteinase assay using purified human IGFBPs and conditioned media collected from HEK293 cells transfected with Papp-aa cDNA or empty vector (mock medium). As shown in [Figure 4A](#fig4){ref-type="fig"}, Papp-aa containing medium efficiently cleaved IGFBP5 and IGFBP4, whereas it did not cleave IGFBP1, 2, 3 and 6 ([Figure 4A](#fig4){ref-type="fig"}).

![Papp-aa is an Igfbp5 proteinase and Papp-aa-mediated Igfbp5 proteolysis in NaR cells is critical.\
(**A**) Purified human IGFBP1, 2, 3, 4, 5, and six was incubated for 2 hr at 28°C with conditioned media collected from HEK293 cells transfected with zebrafish Papp-aa and from Mock transfected cells. For the IGFBP4 group, 100 nM IGF1 was added prior to the initiation of the proteinase assay. The protease reaction was stopped and analyzed by western blotting. (**B**) Conditioned media collected from HEK293 cells co-transfected with Igfbp5b and the indicated plasmid were analyzed by western blotting. Intact and cleaved Igfbp5b bands were indicated. (**C**) Conditioned media collected from HEK293 cells co-transfected with Igfbp3 and the indicated plasmid were analyzed by western blotting. Intact and cleaved Igfbp3 bands were indicated. (**D**) *Tg(igfbp5a:GFP)* fish were raised in E3 embryo medium to 3 days post fertilization (dpf) and transferred to embryo media containing the indicated \[Ca^2+^\]. Eighteen hours later, NaR cells were isolated by FACS. The mRNA levels of the indicated *igfbp* genes were measured and shown. Data shown are Mean ± SEM, n = 4. (**E**) Progenies resulted from *papp-aa^+/-^; igfbp5a^+/-^* and *papp-aa^+/-^; igfbp5a^-/-^* intercrosses were raised in E3 embryo medium to three dpf and transferred to the normal \[Ca^2+^\] (0.2 mM) or low \[Ca^2+^\] (0.001 mM) embryo medium. At five dpf, NaR cells in each fish were labeled by *igfbp5a* mRNA expression and quantified. Each fish was genotyped individually afterward. Quantified data are shown. n = 18 \~ 63 fish/group.\
Figure 4---source data 1.Excel spreadsheet containing quantitative data for [Figure 4](#fig4){ref-type="fig"}.](elife-52322-fig4){#fig4}

The zebrafish genome has no *igfbp4* gene, but contains two paralogous *igfbp5* genes ([@bib2]). To show that zebrafish Papp-aa cleaves Igfbp5a and to clarify the relationship among multiple pappalysins and Igfbp5s, in vitro proteinase assays were carried out using homologous proteins. Both zebrafish Papp-aa and Papp-ab cleaved Igfbp5a, whereas Papp-a2 had little activity ([Figure 3C](#fig3){ref-type="fig"}). We noted a substantial level of Igfbp5a degradation by mock media, indicating the presence of other Igfbp5a degrading proteases in HEK293 cells. In the case of Igfbp5b, it was cleaved by Papp-aa, Papp-ab, and Papp-a2 ([Figure 4B](#fig4){ref-type="fig"}). K128 in human IGFBP5 is critical for PAPP-A-mediated cleavage ([@bib40]; [@bib41]), and this residue is present in zebrafish Igfbp5a (K147 or K148) and Igfbp5b (K144 or K145) ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}). Indeed, changing Igfbp5a K148 to alanine reduced Papp-aa-mediated cleavage, while mutating the neighboring K147 had little effect ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). Likewise, changing Igfbp5b K145 to alanine reduced Papp-aa-mediated Igfbp5b cleavage, while K144A mutation had little effect ([Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}). These results suggest that Papp-aa and Papp-ab, but not Papp-a2, can cleave Igfbp5a and the cleavage site appears to be conserved. We also tested Igfbp3, which is most closely related to Igfbp5 among all the Igfbps ([@bib22]). Papp-aa and Papp-ab did not cleave Igfbp3 and Papp-a2 had very low activity ([Figure 4C](#fig4){ref-type="fig"}).

Gene expression analysis results showed that *Igfbp5a* and *Igfbp2a* are highly expressed in NaR cells ([Figure 4D](#fig4){ref-type="fig"}). The levels of *igfbp5b*, *igfbp1b*, *igfbp3*, and *igfbp6b* mRNA in NaR cells are much lower, and *igfbp2b* and *igfbp6a* are barely detectable ([Figure 4D](#fig4){ref-type="fig"}). Low \[Ca^2+^\] stress treatment did not affect any of these *igfbp* mRNA levels ([Figure 4D](#fig4){ref-type="fig"}). As mentioned above, *papp-aa* but not *papp-ab* is highly expressed in NaR cells ([Figure 1](#fig1){ref-type="fig"}). These gene expression data together with the proteinase assay results suggest that Igfbp5a is likely the primary Papp-aa substrate in NaR cells.

To further test the functional importance of Papp-aa-mediated Igfbp5a proteolytic cleavage in vivo, we crossed *papp-aa^-/-^* and *igfbp5a^-/-^* lines and generated double mutant embryos. Again, the phenotypes of the progeny were analyzed in a blind fashion followed by individual genotyping. As shown in [Figure 4E](#fig4){ref-type="fig"}, under normal \[Ca^2+^\] conditions, NaR cell numbers in *papp-aa^-/-^* fish, *igfbp5a^-/-^* fish, *papp-aa^-/-^;igfbp5a^-/-^* double mutant fish, and siblings were similar and no significant difference was observed ([Figure 4E](#fig4){ref-type="fig"}). While the low \[Ca^2+^\] stress treatment resulted in a significant increase in NaR cell number in the siblings, this increase was abolished in *papp-aa^-/-^* fish, *igfbp5a^-/-^* fish, and *papp-aa^-/-^;igfbp5a^-/-^* double mutant fish ([Figure 4E](#fig4){ref-type="fig"}). These genetic results suggest that Papp-aa-mediated Igfbp5a proteolysis is critical for NaR cell reactivation.

Papp-aa promotes IGF signaling and NaR cell proliferation by increasing bioavailable IGFs {#s2-4}
-----------------------------------------------------------------------------------------

As previously reported ([@bib19]; [@bib46]), low \[Ca^2+^\] stress treatment activates Akt and Tor activity in wild-type fish NaR cells ([Figure 5A and B](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}). This induction was impaired in *papp-aa^-/-^* fish but not in the heterozygous fish ([Figure 5A and B](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}). The low \[Ca^2+^\] stress-induced Akt signaling activity was similarly impaired in *papp-aa^-/-^* single mutant and *papp-aa^-/-^; igfbp5a^-/-^* double mutant fish ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Treatment of wild-type zebrafish larvae with ZnCl~2~ and batimastat also inhibited the low \[Ca^2+^\] stress-induced Akt and Tor activity ([Figure 5C and D](#fig5){ref-type="fig"}).

![Papp-aa acts by regulating IGF-Akt-Tor signaling in NaR cells.\
(**A--B**) Zebrafish embryos of the indicated genotypes were transferred to the low \[Ca^2+^\] medium at three dpf. One day later, they were fixed and stained for phospho-Akt. Representative images are shown in (**A**) and quantitative results in (**B**). Scale bar = 0.1 mm. n = 25 \~ 58 fish/group. (**C--D**) *Tg(igfbp5a:GFP)* fish were transferred to the low \[Ca^2+^\] medium 0--8 µM ZnCl~2~ (**C**) or 200 µM batimastat (**D**) at three dpf. After one day treatment, they were analyzed by immunostaining for phospho-Akt. n = 18 \~ 24 fish/group. \*\*\*\*, p\<0.0001, unpaired two-tailed t test. (**E and F**) Progeny of *papp-aa^+/-^;Tg(igfbp5a:GFP)* intercrosses were injected with *BAC(igfbp5a:mCherry)* or *BAC(igfbp5a:myr-Akt-mCherry)*. They were raised and subjected to the low \[Ca^2+^\] stress test described in [Figure 2A](#fig2){ref-type="fig"}. NaR cells expressing mCherry or myr-Akt were scored as described in [Figure 3](#fig3){ref-type="fig"}. Representative images are shown in (**E**) and quantified data in (**F**). ++, two cell division, +, one cell division, -, no division during the experiment. Scale bar = 20 µm. \*\*\*\*, p\<0.0001 by Chi-square test. Total number of cells is shown above the bar.\
Figure 5---source data 1.Excel spreadsheet containing quantitative data for [Figure 5](#fig5){ref-type="fig"}.](elife-52322-fig5){#fig5}

The above results indicate that Papp-aa promotes NaR cell reactivation via the Akt-Tor signaling pathway. If this is correct, then constitutive activation of this signaling pathway should rescue NaR cell reactivation in *papp-aa*^-/-^ fish. Indeed, genetic mosaic assays showed that targeted expression of myr-Akt, a constitutively active Akt ([@bib38]), restored NaR cell reactivation in *papp-aa^-/-^* fish under to low \[Ca^2+^\] stress ([Figure 5E and F](#fig5){ref-type="fig"}).

Because Papp-aa increases IGF signaling in NaR cells only under low \[Ca^2+^\] stress, we speculated that Papp-aa activity is suppressed and IGF ligands are sequestered in the Igfbp5a/IGF complex under normal \[Ca^2+^\] conditions. If this is correct, then pharmacological disruption of the Igfbp5a/IGF complex should activate IGF signaling and increase NaR cell reactivation under normal \[Ca^2+^\] conditions. To test this idea we used NBI-31772, an aptamer that can displace and release IGF from the IGF/IGFBP complex ([@bib8]). NBI-31772 treatment promoted NaR cell reactivation under normal \[Ca^2+^\] in a concentration-dependent manner ([Figure 6A and B](#fig6){ref-type="fig"}). To test whether this effect of NBI-31772 is indeed mediated via IGF signaling, we co-treated zebrafish larvae with NBI-31772 and BMS-754807, an IGF1 receptor inhibitor and measured the levels of phospho-Akt and phospho-pS6 activity in NaR cells. While NBI-31772 treatment increased Akt and Tor signaling activity, these increases were abolished by BMS-754807 ([Figure 6C and D](#fig6){ref-type="fig"}). Moreover, the effect of NBI-31772 in reactivating NaR cells was abolished by adding BMS-754807, PI3 kinase inhibitor wortmannin, Akt inhibitor MK2260, and Tor inhibitor rapamycin ([Figure 6E](#fig6){ref-type="fig"}; [Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}). Mitogen-activated kinase (MAPK) pathway is another major signaling pathway downstream of the IGF1 receptor ([@bib21]). Immunostaining analysis results showed that NBI-31772 treatment did not change the phospho-Erk levels ([Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}). Co-treatment with the MEK inhibitor U0260 did not affect NBI-31772 treatment-induced NaR cell proliferation ([Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}), indicating MAPK signaling is not involved.

![Disruption the IGF/Igfbp complex activates IGF-Akt-Tor signaling and promotes NaR cell reactivation.\
(**A--B**) *Tg(igfbp5a:GFP)* fish were transferred to normal \[Ca^2+^\] medium containing the indicated doses of NBI-31772 at three dpf. Two days later, NaR cells were quantified. Representative images are shown in (**A**) and quantified data in (**B**). Scale bar = 0.2 mm. n = 25 \~ 27 fish/group. (**C**) Wild-type fish were treated with 90 µM NBI-31772 with or without 0.3 µM BMS-754807 from 3 to 4 dpf. The number of cells positive for phosphorylated Akt staining were quantified and shown. n = 19 \~ 23 fish/group. (**D**) Larvae treated as described in (**C**) were stained for phosph-S6 and quantified. n = 14 \~ 15 fish/group. (**E**) *Tg(igfbp5a:GFP)* fish were treated with NBI-31772 (90 µM) together with BMS-754807 (0.3 µM), MK2206 (8 µM), or Rapamycin (5 µM) from 3 to 5 dpf. NaR cell number was quantified and shown. n = 10 \~ 24 fish/group. (**F**) *Tg(igfbp5a:GFP)* fish were treated with human IGF1 (150 ng/ml) in E3 embryo medium from 3 to 5 dpf. NaR cells were quantified and shown. n = 35 \~ 36 fish/group. \*\*p\<0.01, unpaired t-test. (**G**) Proposed model of Papp-aa function as a \[Ca^2+^\]-regulated molecular switch of IGF signaling in epithelial cells. Left panel: under normal \[Ca^2+^\] conditions, Papp-aa proteolysis activity is suppressed. Igfbp5a is intact and it inhibits IGF signaling by binding to IGFs and prevents their binding to the IGF1 receptor. The IGF- PI3 kinase-Akt-Tor signaling is inhibited in NaR cells. Right panel: under low \[Ca^2+^\] conditions, Papp-aa activity is increased. This increases Igfbp5a proteolytic cleavage and releases IGFs from the Igfbp5a/IGF complex. Bioavailable IGFs binds to IGF1 receptor and activates PI3 kinase-Akt-Tor signaling in NaR cells and promotes their reactivation and proliferate.\
Figure 6---source data 1.Excel spreadsheet containing quantitative data for [Figure 6](#fig6){ref-type="fig"}.](elife-52322-fig6){#fig6}

If the limiting step under normal \[Ca^2+^\] is indeed the lack of bioavailable IGFs, then administering free IGF1 should stimulate NaR cell reactivation. This reasoning was tested by treating *Tg(igfbp5a:GFP)* embryos with free human IGF1. As shown in [Figure 6F](#fig6){ref-type="fig"}, IGF1 treatment significantly increased NaR cell reactivation and proliferation under normal \[Ca^2+^\]. Likewise, fish (salmon) IGF1 treatment also increased NaR cell reactivation and proliferation under normal \[Ca^2+^\] conditions ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}).

Discussion {#s3}
==========

In this study, we uncovered a novel mechanism regulating calcium homeostasis and bone calcification using the zebrafish model. Zebrafish have been used with growing success to model various pathological defects affecting human skeletal tissues ([@bib39]). Zebrafish shares many similarities in bone biology with mammals, including bone formation, resorption, mineralization, and extracellular matrix maintenance ([@bib39]). Unlike mammals, however, zebrafish bone is acellular and osteoclasts are mononucleated ([@bib39]). Calcium, an important bone component, is an essential ion and plays important roles in development and adult physiology. Calcium homeostasis is regulated by many hormonal circuits. Many hormones known to be critical to mammalian bone mineralization, including Vitamin D3, parathyroid hormone, calcitonin were found to be important in zebrafish ([@bib43]). There are also examples of hormones first discovered in fish. Stanniocalcin (Stc), for example, was initially discovered in bony fish as a hypocalcemic hormone ([@bib52]). It was later found that humans and other mammals have two STC genes ([@bib68]). Recent studies suggest that human STC1 and STC2 are potent PAPP-A and A2 inhibitors in vitro ([@bib33]; [@bib37]). In this study, we provide genetic, biochemical, and pharmacological evidence showing that Papp-aa and IGF signaling regulates bone calcification by promoting Ca^2+^-transporting epithelial cell reactivation and proliferation. Mechanistically, Papp-aa acts by cleaving Igfbp5a and activating IGF1 receptor-mediated Akt and Tor signaling in NaR cells in response to low \[Ca^2+^\] stress.

Using an optimized in situ hybridization protocol and qPCR analysis of FACS isolated NaR cells, we found that Papp-aa is highly expressed in NaR cells. This was further confirmed by double color in situ hybridization. Our genetic analysis results showed that deletion of Papp-aa, but not the closely related Papp-ab, abolished low \[Ca^2+^\] stress-induced NaR cell quiescence-proliferation transition. There was a complete lack of calcified bone in *papp-aa^-/-^* fish at seven dpf. Although low levels of calcification were detected in some components of the craniofacial skeleton in *papp-aa^-/-^* fish at 10 and 12 dpf, the mutant fish had no calcified vertebrate in these late stages. The defective bone calcification and impaired NaR cell reactivation suggest that *papp-aa^-/-^* fish suffered and died prematurely from Ca^2+^ deficiency, likely due to insufficient epithelial Ca^2+^ uptake. The action of Papp-aa on epithelial cells requires its proteinase activity. Reintroduction of wild-type Papp-aa, but not a proteolytically inactivated mutant, reactivated NaR cells in the *papp-aa^-/-^* mutant fish. Likewise, treatment of wild-type fish with two distinct metalloproteinase inhibitors impaired NaR cell reactivation. When STC1 and STC2 was specifically expressed in NaR cells separately, they both blocked low \[Ca^2+^\] stress-induced NaR cell quiescence-proliferation transition, indicating the importance of local endogenous Papp-aa in NaR cells.

We provide several lines of independent evidence showing that Papp-aa regulates NaR cell quiescence-proliferation transition via proteolytically cleaving locally expressed Igfbp5a and activating IGF signaling. We have previously reported that Igfbp5a is specifically expressed in NaR cells ([@bib19]; [@bib45]). In this study, we found that in addition to Igfbp5a, Igfbp2a is also highly expressed in NaR cells. The expression levels of other Igfbps including Igfbp5b are low in NaR cells. Our biochemical analysis showed that Papp-aa efficiently cleaved human IGFBP4 and IGFBP5 but not IGFBP2 and other IGFBPs. Since the zebrafish genome does not have an igfbp4 gene, we postulated that Igfbp5a is the main Papp-aa substrate in NaR cells. We found that while Papp-aa cleaved Igfbp5a, Papp-a2 had no such activity. Although Papp-ab can also cleave Igfbp5a, its expression in NaR cells is relatively low. Another line of evidence came from *papp-aa^-/-^* fish. The impaired NaR cell reactivation in *papp-aa^-/-^* fish was accompanied with reduced IGF1 receptor-mediated Akt-Tor signaling activity. Likewise, inhibition of Papp-aa proteolytic activity resulted in reduced Akt-Tor activity in NaR cells. Importantly, targeted expression of a constitutively active Akt in *papp-aa^-/-^* NaR cells was sufficient to rescue their reactivation and proliferation, supporting the notion that Akt mediates Papp-aa action in NaR cells. Akt is involved in signal transduction of a number of growth factors and hormones. However, the fact that addition of human or fish IGF-1 was sufficient to activate NaR cell proliferation strongly argues that IGF signaling is critical.

A most interesting finding made in this study is that Papp-aa-mediated Igfbp5a proteolysis in NaR cells is suppressed under normal \[Ca^2+^\] conditions. This conclusion is supported by the fact that genetic deletion of Papp-aa had no effect on Akt-Tor signaling or NaR cell proliferation when fish were kept under normal \[Ca^2+^\] conditions, while it abolished IGF signaling and NaR cell reactivation and proliferation under low \[Ca^2+^\] stress. Pharmacological inhibition or targeted expression of STC1/2 affected IGF signaling in NaR cells only under low \[Ca^2+^\]. Furthermore, pharmacological disruption of the Igfbp5/IGF complex by NBI-31772 treatment was sufficient to increase Akt and Tor activity and promote NaR cell reactivation under normal \[Ca^2+^\] conditions. This effect of NBI-31772 is clearly mediated by IGF signaling because 1) NBI-31772 increased Akt and Tor signaling activity in an IGF1 receptor-dependent manner, and 2) NBI-31772 treatment-induced NaR cell proliferation was abolished by co-treatment with inhibitors blocking the IGF1 receptor, Akt, PI3 kinase, and Tor activity. NBI-31772 not only binds to IGFBP5, but also other IGFBPs. Indeed, our RNA expression analysis results showed that not only Igfbp5a, but also Igfbp2a is highly expressed in NaR cells. While the levels of *igfbp1b*, *igfbp3*, *igfbp5b*, and *igfbp6b* mRNA in NaR cells are low, they are nonetheless detectable. Therefore, we cannot exclude the possibility that NBI-31772 may also affect IGFs bound to other Igfbps. However, regardless of whether Papp-aa acts via Igfbp5a alone or together with other Igfbps, the NBI-31772 results clearly indicate that latent IGF is present in/near NaR cells under normal \[Ca^2+^\], suggesting the limiting step may be the release of IGFs from the Igfbp/IGF complexes. The zebrafish genome contains 4 IGF genes ([@bib73]). Currently, there are no antibodies available against these zebrafish IGF ligands, making it impossible to measure IGF release after NBI-31772 treatment. To circumvent this problem, we treated zebrafish embryos with free IGF1 following a recent paper ([@bib1]). Addition of either human or fish IGF-1 increased NaR cell proliferation, supporting the idea that bioavailability of IGFs is critical.

IGFBP5/Igfbp5a has been shown to both inhibit and potentiate IGF actions in mammalian and zebrafish cells in vitro and in vivo ([@bib69]; [@bib70]; [@bib54]; [@bib18]; [@bib46]; [@bib22]). How the same protein exerts these opposing biological effects was not well understood. The data presented in this study suggests that Papp-aa-mediated Igfbp5a proteolysis functions as a \[Ca^2+^\]-regulated molecular switch to turn on and off IGF signaling in NaR cells. Under normal conditions, Papp-aa activity is suppressed at low levels and Igfbp5a is intact. Intact Igfbp5a acts as an IGF inhibitory protein as it binds IGF ligands and prevents its binding and activation of the IGF1 receptor. Under low \[Ca^2+^\] stress, Papp-a activity is increased. Papp-aa proteolytically cleaves Igfbp5a and releases IGFs from the Igfbp5a/IGF complex to activate IGF1 receptor-mediated PI3 kinase-Akt-Tor signaling, thus promoting NaR cell proliferation ([Figure 6G](#fig6){ref-type="fig"}). This model provides a mechanistic explanation for the seemingly opposite biological effects of Igfbp5a and IGFBP5. We suggest that when Igfbp5a/IGFBP5 is present in a microenvironment containing active Papp-aa, it potentiates IGF action because Papp-aa-mediated Igfbp5a proteolysis releases IGFs from the Igfbp5a/IGF complex. When Igfbp5/IGFBP5 is expressed in tissues without Papp-aa or with Papp-aa activity inhibited, it inhibits IGF action as Igfbp5a binds to IGFs and sequesters IGFs in the IGF/Igfbp5a complex.

While it has become evident that Igfbp5/IGFBP-5 acts as the pivot point in a switch between regulated states of inhibition and activation of IGF signaling, many questions remain. For example, mutation of Igfbp5a K148 to alanine reduced, but did not abolish Papp-aa cleavage, suggesting there may be other residues and/or other proteinases involved. Although Papp-ab can cleave Igfbp-5a efficiently in vitro, Papp-ab is clearly not involved in NaR cell reactivation in vivo as demonstrated by the *papp-ab^-/-^* mutant fish data. Whether Papp-ab-mediated Igfbp5a plays similar role in switching on/off IGF signaling in different tissues or different life stages awaits further investigation. All three pappalysin family members can proteolytically cleave Igfbp5b efficiently but the functional role of Igfbp5b and its regulations by pappalysins are unclear. We noted that Igfbp5a was partially degraded in the absence of Papp-aa. This was evident in the mock group in [Figure 3C](#fig3){ref-type="fig"}, [Figure 4A](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}, suggesting the presence of other proteinases in the conditioned media used. This is consistent with the fact that human IGFBP5 is degraded by a host of proteinases. In addition to PAPP-A and -A2, thrombin, elastase, cathepsin G, C1s, ADAM 9, ADAM 12 s, MMP-1, and MMP-2 etc. have been shown to degrade IGFBP5 in vitro ([@bib22]). Future studies are needed to elucidate whether any of these proteolytic modifications play similar roles in turning on and off IGF signaling.

Another important remaining question is how Papp-aa proteolytic activity is suppressed under normal \[Ca^2+^\] conditions. Since changes in external \[Ca^2+^\] did not change *papp-aa* mRNA level nor *igfbp5a* mRNA level, and because addition of free IGF1 or pharmacological disruption of the Igfbp/IGF complex was sufficient to activate IGF signaling and induce NaR cell reactivation under normal \[Ca^2+^\] conditions, we speculate that there is a \[Ca^2+^\]-regulated post-transcriptional mechanism(s) at work. One possible candidate is Stc. Recent studies showed that mammalian PAPP-A proteolytic activity is inhibited by STC1 and STC2 ([@bib33]; [@bib37]). In this study, we showed that overexpression of STC1 or STC2 in NaR cells impaired Papp-aa-induced IGF signaling and NaR cell reactivation in vivo. Stc protein was originally discovered in bony fish as a hypocalcemic hormone ([@bib52]). We now understand that the human genome has two *STC* genes while the zebrafish genome has four *stc* genes ([@bib68]). The mRNA levels of *stc1* but not the other *stc* genes are significantly higher in fish raised in high \[Ca^2+^\] medium compared to those kept in low \[Ca^2+^\] medium ([@bib12]). Forced expression and morpholino-based knockdown of Stc1 altered NaR cell density and Ca^2+^ uptake ([@bib58]), although these manipulations have also changed HR and NCC cell density and the uptake of other ions ([@bib12]). Whether endogenous Stc1 and/or other Stc proteins are responsible for the \[Ca^2+^\]-dependent suppression of Papp-aa activity awaits future studies. It is also worth noting that both human PAPP-A and zebrafish Papp-aa contain three Lin-12/Notch repeat (LNR) modules ([@bib6]; [@bib64]). LNR modules were initially discovered in the Notch receptor family ([@bib47]). These modules can bind to Ca^2+^ and are involved in calcium depletion-induced Notch receptor cleavage and activation ([@bib53]; [@bib59]; [@bib27]). The three LNR modules in human PAPP-A can bind Ca^2+^ and form a Ca^2+^-dependent substrate binding exosite ([@bib6]; [@bib63]; [@bib48]). Whether these LRN modules are involved in the \[Ca^2+^\]-dependent suppression of Papp-aa activity is unclear.

In summary, the results of this study have uncovered a novel function of Papp-aa in reactivating quiescent epithelial cells and regulating bone calcification. Papp-aa promotes quiescent NaR cells to re-enter the cell cycle by locally cleaving Igfbp5a and activating IGF signaling in a physiological context-dependent manner. These findings not only provide new insights into the physiological functions of the pappalysin family zinc metalloproteinases, but also have important implications in the regulation of cellular quiescence. Reactivation of quiescent cells is critical for tissue repair, regeneration, and adult stem cell renewal ([@bib11]; [@bib56]; [@bib67]). Genetic studies in flies and mice suggest that insulin/IGF-PI3 kinase-Akt-Tor signaling pathway is critical in adult stem cell quiescence regulation ([@bib10]; [@bib32]; [@bib71]). In *Drosophila,* neural stem cells are reactivated in response to dietary amino acids and this has been attributed to insulin produced in glia cells ([@bib7]; [@bib55]; [@bib30]). Reactivation of the imprinted IGF2 gene expression or activation of mTOR in mouse adult hematopoietic stem cells (HSCs) promotes them to exit quiescence and proliferate ([@bib9]; [@bib60]). IGF2 also stimulates adult neural stem cell and intestinal stem cell reactivation in mice ([@bib24]; [@bib71]; [@bib72]). Elevated PI3 kinase-Akt-Tor activity stimulates reactivation of adult stem cells in *Drosophila* and mice ([@bib7]; [@bib55]; [@bib26]; [@bib28]). Although the role of insulin/IGF-PI3 kinase-Akt-Tor signaling in reactivating quiescent adult stem cells has been demonstrated across a wide range of species, the mechanisms underlying its cell type- and cell state-specific activation are poorly understood. The similarities among mammals, flies, and fish imply evolutionarily conserved and general mechanisms at work. Future studies are needed to determine whether the PAPP-A/A2-mediated IGFBP proteolytic cleavage plays similar roles in the reactivation of adult stem cells and/or other quiescent cells.

Materials and methods {#s4}
=====================

Experimental animals {#s4-1}
--------------------

Zebrafish were raised and crossed according to the standard husbandry guidelines ([@bib62]). Embryos and larvae were raised at 28.5°C in standard E3 embryo medium ([@bib62]) unless stated otherwise. Two additional embryos media containing 0.2 mM \[Ca^2+^\] and 0.001 mM \[Ca^2+^\] (referred to as normal and low \[Ca^2+^\] medium, respectively) were prepared as previously reported ([@bib19]) and used. 0.003% (w/v) N-phenylthiourea (PTU) was added to the media to inhibit pigmentation. *Tg(igfbp5a:GFP)* fish were generated in a previous study ([@bib45]). The *papp-aa^p170/^*^+^ fish were obtained from the Marc Wolman lab. All experiments were conducted in accordance with the guidelines approved by the Institutional Committee on the Use and Care of Animals, University of Michigan and the Danish *The Animal Experiments Inspectorate* (permit numbers 2017-15-0201-01369 and 2017-15-0202-00098).

Chemicals and reagents {#s4-2}
----------------------

Chemical and molecular biology reagents were purchased from Fisher Scientific (Pittsburgh, PA, USA) unless stated otherwise. BMS-754807 was purchased from JiHe Pharmaceutica (Beijing, China) and NBI-31772 from Tocris Bioscience (Ellisville, MO, USA). Liberase TM, Alizarin Red S, ZnCl~2~, and batimastat were purchased from Sigma (St. Louis, MO, USA). MK2206 was purchased from ChemieTek (Indianapolis, IN). Rapamycin was purchased from Calbiochem (Gibbstown, NJ). Antibodies (phospho-Akt, phospho-S6, and phospho-Erk) were purchased from Cell Signaling Technology (Danvers, MA, USA). Restriction enzymes were purchased from New England BioLabs (Ipswich, MA, USA). Primers, cell culture media, antibiotics, TRIzol, M-MLV reverse transcriptase, Alexa Fluor 488 Tyramide SuperBoost Kit, and Tetramethylrhodamine (TMRM) were purchased from Life Technologies (Carlsbad, CA, USA). Anti-Digoxigenin-POD and Anti-Digoxigenin-AP antibodies were purchased from Roche (Basel, Switzerland).

Fluorescence activated cell sorting (FACS) and qPCR {#s4-3}
---------------------------------------------------

FACS was performed to isolate NaR cells from *Tg*(*igfbp5a:GFP*) fish as described ([@bib45]). Briefly, *Tg*(*igfbp5a:GFP*) larvae were raised in E3 medium to 3 days post fertilization (dpf) then transferred to normal or low \[Ca^2+^\] embryo media for 18 hr. Single cell suspensions were made using Liberase TM (0.28 Wünsch units/ml in HBSS). EGFP-positive cells were sorted using FACSAria Cell Sorter (BD Biosciences, Franklin Lakes, NJ). Total RNA was isolated using TRIzol LS reagent. Total RNA was reverse transcribed using SuperScript III Reverse Transcriptase. RNaseOUT Recombinant Ribonuclease Inhibitor was added into the reverse transcript system to protect RNA from degradation. M-MLV Reverse Transcriptase was used for reverse transcription. qPCR was carried out using SYBR Green (Bio-Rad, Hercules, CA) on a StepONE PLUS real-time thermocycler (Applied Biosystems, Foster City, CA). Primers for qPCR are listed in [Supplementary file 1](#supp1){ref-type="supplementary-material"}.

Generation of *papp-ab^-/-^* (Auzf1) fish lines using CRISPR/Cas9 {#s4-4}
-----------------------------------------------------------------

The sgRNA targeting *papp-ab* (5'-GGGAAAGCAGCCCAGGTCGG(CGG)−3') was mixed with nCas9n-encoding mRNA in vitro transcribed from linearized pCS2-nCas9n and co-injected into wild-type embryos at the 1 cell stage as described ([@bib66]). After using a subset of F0 embryos to confirm the presence of indels, the remaining F0 embryos were raised to adulthood and crossed with wild-type fish. F1 fish were then raised to the adulthood and genotyped. After confirming indels by DNA sequencing, the heterozygous F1 fish were intercrossed to generate F2 fish. The mutation is a seven nucleotide deletion (238--244 bp) in the *papp-ab* CDS, resulting in a premature stop codon in exon 1.

Genotyping {#s4-5}
----------

dCAPS assay and HRMA methods were used to genotype *papp-aa* mutant. The dCAPS assay was performed following a published method ([@bib64]). The region containing the *papp-aa* mutation was amplified with the dCAPS primers ([Supplementary file 1](#supp1){ref-type="supplementary-material"}), then digested by Mse1. To genotype a large number of *papp-aa^-/-^* mutant fish, HRMA was performed as previously reported ([@bib46]) using the *papp-aa*-HRMA primers ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). The *papp-ab* genotyping was performed by PCR using the primers 5'-ATACGCGTCTTGACAGGCTT-3' and 5'-TAAGCAAACCAAACCTCCGA-3' followed by Exonuclease I/FastAP Thermosensitive Alkaline Phosphatase treatment and Sanger sequencing using primer 5'-ATACGCGTCTTGACAGGCTT-3'.

Whole-mount in situ hybridization and immunostaining {#s4-6}
----------------------------------------------------

A DNA fragment encoding part of Papp-aa sequence was amplified using primers in [Supplementary file 1](#supp1){ref-type="supplementary-material"}. The PCR product was cloned in pGEM-T easy plasmid. The Digoxygenin-UTP labeled sense and antisense riboprobes were synthesized as previously reported ([@bib61]). Zebrafish larvae were fixed in 4% paraformaldehyde, permeabilized in methanol, and analyzed by whole mount immunostaining or in situ hybridization analysis as described previously ([@bib19]).

For double color in situ hybridization and immunostaining, *papp-aa* mRNA signal was detected using an anti-DIG-POD antibody (Roche), followed by Alexa 488 Tyramide Signal Amplification (Invitrogen). After in situ hybridization analysis, the stained larvae were washed in 1xPBST then incubated with a GFP antibody overnight at 4°C. Larvae were then stained with a Cy3 conjugated Goat anti-Rabbit IgG antibody (Jackson ImmunoResearch, West Grove, PA). Images were acquired using a Nikon Eclipse E600 Fluorescence Microscope with PMCapture Pro six software.

Plasmid and BAC constructs and BAC-mediated genetic mosaic assay {#s4-7}
----------------------------------------------------------------

The expression plasmids for Papp-aa, Papp-ab, Papp-a2, Igfbp5a, Igfbp5a, and Igfbp3 have been previously reported ([@bib35]; [@bib36]). In order to generate cleavage resistant mutants of Igfbp5a and Igfbp5b, the following residues were mutated to alanine individually or in combination: Igfbp5a K147 and K148, Igfbp5b K144 and K145. Mutations were introduced by site-directed mutagenesis using QuikChange (Stratagene). The aforementioned plasmids were used as templates, and the primers used are shown in [Supplementary file 1](#supp1){ref-type="supplementary-material"}. All constructs were verified by sequencing analysis. The BAC constructions were generated as reported ([@bib45]). Briefly, zebrafish Papp-aa and Papp-aa (E501A) cDNA were released from pcDNA3.1mH(+)A plasmids and sub-cloned into pIRES2-mCherry plasmid using SacII and BamH1 restriction sites. The papp-aa/papp-aa (E501A)-IRES2-mCherry-KanR cassette DNAs were amplified by PCR using primers which contain a 50 bp homology region to *igfbp5a*. The DNA cassettes were inserted into the *igfbp5a* BAC construct to replace the *igfbp5a* sequence from the start codon to the end of the first exon through homologous recombination. A similar cloning strategy was used to generate *BAC(igfbp5a:hSTC1-IRES-mCherry)* and *BAC(igfbp5a:hSTC2-IRES-mCherry)* constructs. The construction of *BAC(igfbp5a: myrAkt -mCherry)* was previously reported ([@bib46]). All constructs used were confirmed by DNA sequencing at the University of Michigan DNA Sequencing Core Facility.

For Tol2 transposon-mediated genetic mosaic assay, the validated BAC DNA and Tol2 mRNA were mixed and injected into *Tg(igfbp5a:GFP)* embryos at the 1 cell stage. The embryos were raised and subjected to the low \[Ca^2+^\] stress test as shown in [Figure 2A](#fig2){ref-type="fig"}. Cells co-expressing mCherry and GFP were identified and scored for cell division following a reported scoring system ([@bib46]).

Live imaging and microscopy {#s4-8}
---------------------------

NaR cells were quantified as previously reported ([@bib45]). To visualize NaR cells, progeny of *papp-aa^+/-^;Tg(igfbp5a:GFP)* fish intercrosses were anesthetized with 0.63 mM tricaine. Live larvae were embedded in 0.3% low melting point agarose containing 0.63 mM tricaine and placed in a chamber in which the bottom was sealed with a 0.16--0.19 mm slide. The solidified agarose was then immersed in 1 ml normal \[Ca^2+^\] medium. The bright-field and GFP fluorescent images were acquired using a Leica TCS SP8 confocal microscope equipped with HCPL APO 93X/1.30 GLYC. After images were obtained, the normal \[Ca^2+^\] medium was washed with low \[Ca^2+^\] medium three times. The samples were then incubated in low \[Ca^2+^\] medium for 8 hr and imaged again. LAS X and Image J were used for image analysis.

Morphology analysis {#s4-9}
-------------------

Body length, defined as the curvilinear distance from the head to the end of caudal tail, was measured as reported ([@bib46]). Somite number and head-trunk angles were measured manually as reported ([@bib34]). Alizarin red staining was performed as previously described ([@bib46]). Images were captured with a stereomicroscope (Leica MZ16F, Leica, Wetzlar, Germany) equipped with a QImaging QICAM camera (QImaging, Surrey, BC, Canada).

Drug treatment {#s4-10}
--------------

Fish were treated with BMS-754807, ZnCl2, batimastat, and other drugs as reported previously ([@bib45]). Drugs used in this study were dissolved in DMSO and further diluted in water. ZnCl~2~ was dissolved in distilled water. Drug treatments began at 3dpf unless stated otherwise. Drug solutions were changed daily. The samples were collected for immunostaining after 24 hr of treatment or for in situ hybridization after 48 hr of treatment. The IGF1 treatment experiment was carried out as reported by [@bib1]. *Tg(igfbp5a:GFP)* fish were treated with recombinant fish (salmon) and human IGF-1 at 150 ng/ml (GroPrep, dissolved in 10 mM HCl and diluted in E3 embryo medium) from 3 dpf to five dpf. NaR cells were quantified as previously described ([@bib46]).

Cell culture {#s4-11}
------------

Human embryonic kidney (HEK) 293 cells were cultured in DMEM (HEK 293) supplemented with 10% FBS, penicillin, and streptomycin in a humidified-air atmosphere incubator containing 5% CO~2~. Conditioned media were prepared as previously reported ([@bib23]).

Proteolytic assays and western blotting {#s4-12}
---------------------------------------

For in vitro proteinase assay, conditioned media were harvested from HEK293 cells transfected with zebrafish Igfbp5a, Igfbp5b, Igfbp3, Papp-aa, Papp-ab, Pappa2, and Papp-aa E501A plasmid alone or together. Conditioned media from MOCK transfected cells were used as the control. The media were concentrated and used in the proteinase assay following published conditions ([@bib36]). The proteinase assay was performed as described ([@bib36]). Briefly, conditioned media collected from HEK293 cells transiently transfected with Papp-aa or Papp-ab was mixed in a 1:1 ratio with media containing either Igfbp5a, Igfbp5b or Igfbp3 + 100 nM IGF-II and incubated at 28°C. The reactions were stopped at different time points by adding 4x NuPAGE LDS sample buffer containing 75 mM EDTA and 4 mM PMSF. Next, proteins were separated by non-reducing SDS-PAGE and visualized by western blotting as previously described ([@bib5]) using monoclonal anti c-myc antibody 9E10 (Thermo Fisher) 1:1000 and HRP-conjugated rabbit anti-mouse (P0260, DAKO) 1:2000.

Statistical analysis {#s4-13}
--------------------

Values are shown as mean ± standard error of the mean (SEM). Statistical significance between experimental groups was determined using an unpaired t test, one-way ANOVA followed by Tukey's multiple comparison test, Logrank test, or Chi-square test. Statistical significances were accepted at p\<0.05 or greater.
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The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

General Assessment:

While it has been known for some time that plasma protein-A (PAPP-A) loss impacts bone, the mechanism has not been completely explored. The reviewers find that this paper utilizes a zebrafish model, to provide evidence that PAPP-aa (zebrafish paralog) activity in ionocytes (NaR cells, similar to human intestinal endothelial cells) is calcium dependent. They then explore an alternative mechanism by which the PAPP-A protease regulates IGF-1 bioavailability to the IGF-1 receptor.

Central conclusions:

1\) They have determined that PAPP-aa protease regulates intestinal calcium transport to an extent that this alters skeletal calcification within the intact zebrafish.

2\) They demonstrated that expression of PAPP-aa was required for ionocyte activation and that inhibition of PAPP-aa impaired ionocyte activation.

3\) Mechanistically, these data suggest that PAPP-aa contributes to the proteolysis of the IGFBP5-IGF-1 complex, that this is co-incident with the activation of the Akt-Tor pathway and thus initiating ionocyte cell proliferation.

Essential revisions:

1\) There was significant concern raised during review about specificity of PAPP-aa in the zebrafish with regards to cleavage of just Igfbp5a. The data regarding the PAPP-aa mutant clearly show that PAPP-aa is required for this activity. The prospect that PAPP-aa might be cleaving other IGFBPs and other non-Igfbp peptides was raised by multiple reviewers. A limitation of this study is that this possibility is not addressed. It was felt that alternative explanations of the results need to be more clearly presented.

2\) While it was acknowledged that it is possible that PAPP-aa\'s mechanisms of action is via IGF-1, reviewers felt that this was not definitively demonstrated in this paper. The limitations of the data presented in Figure 6 were not fully discussed and no definitive evidence that free IGF-I is actually increased was shown. The reviewers point out that the NBI inhibitor binds to multiple IGF binding proteins as well as other proteins, including EGF binding proteins, therefore it is not a mono specific agent for IGFBP-5, particularly at the concentration used in this study. A positive control showing that IGF-I was released was considered to be important. Further, more discussion regarding the limitations needs to be provided.

3\) It was felt that the data presented linking Igfbp5, IGF-1 and PAPP-aa was thin. The reviewers wished to see results from a double Igfbp5a and Papp-aa deletion mutant. The rational was that if Papp-aa acts through Igfbp5a, there should be no difference between *papp-aa^-/-^ igfbp5a^-/-^* fish and *papp-aa^+/+^ igfbp5a^-/-^* fish.

4\) Expression of the constitutively active Akt mutant partially reversing the changes in the signaling pathway is reasonable evidence that the Akt pathway is involved in mediating the effects of PAPP-aa; however multiple growth factors as well as nutrients can activate the Akt pathway. IGF-I is a cofactor for multiple other growth factors and therefore simply inhibiting the IGF receptor with a relatively high concentration of a kinase inhibitor was not considered adequate specificity data. This limitation was not discussed.

5\) There is one experiment wherein a cleavage site mutant of IGFBP-5a was slightly changed in terms of proteolytic degradation in the presence of activated PAPP-aa, but the data are not definitive. It was felt that an experiment showing this mutant could alter the biologic response was required.

6\) There is an extensive paragraph about PAPP-A in the Discussion and an inferential comment to relating to PAPP-aa since it contains the same three modules that are important for PAPP-A activation. However, PAPP-A has different substrates therefore it\'s activity may not be comparable to PAPP-aa. This paragraph should be edited to deemphasize the importance of this possible correlation in light of the limitations already raised.

7\) The model presented in Figure 6F is consistent with the results of the present study, but does not explain a previous study (described in the Introduction), in which deletion of Igfbp5a reduced calcified bone mass, an observation similar to deletion of PAPP-aa (Figure 2G). This previous study also described that deletion of Igfbp5a \"blunted the low \[Ca^2+^\] stress-induced IGF signaling and NaR cell proliferation\". However, at low \[Ca^2+^\], Igfbp5a is being proteolyzed by PAPP-aa, so why would it matter if it is deleted? Deletion of Igfbp5a would be expected to have effects opposite to those of deleting PAPP-aa (which would increase intact Igfbp5a levels). The Discussion states: \"Igfbp5a is critical in activating IGF signaling and promoting adaptive epithelial growth by reactivating NaR cells\" and yet the model in Figure 6F suggests that Igfbp5a maintains quiescence. There should be some acknowledgement/explanation of this contradiction.

8\) There is mention of the rescue of the PAPP-aa mutants with wild-type PAPP-aa, but no mention of whether this rescued the lethal phenotype.

9\) The impact statement should be reworded, as it is not clear what \"quiescence exit decision\" means without reading the paper.

10.7554/eLife.52322.sa2

Author response

> Essential revisions:
>
> 1\) There was significant concern raised during review about specificity of PAPP-aa in the zebrafish with regards to cleavage of just Igfbp5a. The data regarding the PAPP-aa mutant clearly show that PAPP-aa is required for this activity. The prospect that PAPP-aa might be cleaving other IGFBPs and other non-Igfbp peptides was raised by multiple reviewers. A limitation of this study is that this possibility is not addressed. It was felt that alternative explanations of the results need to be more clearly presented.

We agree that demonstrating the specificity is critical. To address this concern, we have performed additional proteinase assays. As shown in Figure 4A, Papp-aa efficiently cleaved IGFBP5 and IGFBP4, whereas it did not cleave IGFBP1, -2, -3, and -6. This finding is in good agreement with published mammalian studies (Oxvig, 2015; Conover and Oxvig, 2018). Zebrafish genome does not contain any *igfbp4* gene, but it has 2 igfbp5 genes and several other igfbp genes. We mapped the expression profiles of these *igfbp* genes in NaR cells. The new results, shown in Figure 4D, showed that *igfbp2a* and *igfbp5a*mRNA is highly expressed in NaR cells. The levels of other *igfbp* genes are much lower. Among the 3 pappalysin family members, Papp-aa and Papp-ab can both proteolytically cleave Igfbp5a, while Papp-a2 had little activity (Figure 3C). In comparison, Igfbp5b can be cleaved by all 3 pappalysin family members (Figure 4B) and Igfbp3 can be degraded by Papp-a2 only, albeit at very low levels (Figure 4C). These data together with the data shown in Figure 1, suggest that Igfbp5a is likely an important substrate of Papp-aa in NaR cells.

To further address the specificity issue in vivo, we generated a new mutant fish line by deleting the paralogous *papp-ab* gene using CRISPR/Cas9. The new results shown in Figure 2---figure supplement 2, showed that genetic deletion of Papp-ab had no effect on low \[Ca^2+^\] stress-induced NaR cell reactivation and proliferation. These new data argues strongly that Papp-aa-mediated cleavage of Igfbp-5a is critical in NaR cells.

> 2\) While it was acknowledged that it is possible that PAPP-aa\'s mechanisms of action is via IGF-1, reviewers felt that this was not definitively demonstrated in this paper. The limitations of the data presented in Figure 6 were not fully discussed and no definitive evidence that free IGF-I is actually increased was shown. The reviewers point out that the NBI inhibitor binds to multiple IGF binding proteins as well as other proteins, including EGF binding proteins, therefore it is not a mono specific agent for IGFBP-5, particularly at the concentration used in this study. A positive control showing that IGF-I was released was considered to be important. Further, more discussion regarding the limitations needs to be provided.

We appreciate this concern. As shown in Figure 6, addition of NBI-31772 was sufficient to increase Akt and Tor activity and promote NaR cell reactivation under normal \[Ca^2+^\] conditions. This effect of NBI-31772 is clearly mediated by IGF signaling because 1) NBI-31772 increased Akt and Tor signaling activity in an IGF1 receptor-dependent manner (Figure 6C and 6D), and 2) NBI-31772 treatment-induced NaR cell proliferation was abolished by co-treatment with inhibitors blocking the IGF1 receptor, PI3 kinase, Akt, and Tor activity (Figure 6E; Figure 6---figure supplement 1). Furthermore, NBI-31772 treatment did not alter pErk signaling and MEK inhibitor U0216 did not inhibit NBI-31772-induced NaR cell proliferation (Figure 6---figure supplement 1). These data suggest that the effect of NBI on NaR cells is mediated by IGF1 receptor-PI3 kinase-Akt-Tor signaling.

We agree that the NBI inhibitor is not a mono specific agent for IGFBP-5. Our new gene expression analysis results (Figure 4D) show that in addition to Igfbp5a, Igfbp2a is also highly expressed in NaR cells. The levels of *igfbp1b, igfbp3, igfbp5b,* and *igfbp6b*mRNA in NaR cells are much lower, while those of *igfbp2b* and *igfbp6a* are barely detectable. In the revised manuscript, we have discussed the possibility that NBI may also affect other Igfbps (Discussion paragraph four).

Zebrafish has 4 IGF ligand genes (Zou et al., 2009). Currently, antibodies against these IGFs are not available and there are currently no tools to measure free IGFs in these or other cells in vivo. We have discussed these limitations in the revised manuscript (Discussion paragraph four). To circumvent this problem, we took an alternative approach following a recent paper by Alassaf et al., 2019. We found that adding free human or fish IGF1 was sufficient to activate NaR cell proliferation (Figure 6F and Figure 6---figure supplement 2). These new data have provided additional evidence supporting the idea that bioavailable IGFs are important.

> 3\) It was felt that the data presented linking Igfbp5, IGF-1 and PAPP-aa was thin. The reviewers wished to see results from a double Igfbp5a and Papp-aa deletion mutant. The rational was that if Papp-aa acts through Igfbp5a, there should be no difference between papp-aa^-/-^ igfbp5a^-/-^ fish and papp-aa^+/+^ igfbp5a^-/-^ fish.

Following this suggestion, we have obtained *papp-aa^-/-^* and *igfbp5a^-/-^* double mutant embryos and compared them to *papp-aa^-/-^* single mutant embryos. As shown in Figure 4E, no differences in NaR cell reactivation were found between *papp-aa^-/-^*single and *papp-aa^-/-^: igfbp5a^-/-^* double mutant fish.

We also measured pAkt levels in these fish and found no difference. These data results are presented in Figure 5---figure supplement 1B.

> 4\) Expression of the constitutively active Akt mutant partially reversing the changes in the signaling pathway is reasonable evidence that the Akt pathway is involved in mediating the effects of PAPP-aa; however multiple growth factors as well as nutrients can activate the Akt pathway. IGF-I is a cofactor for multiple other growth factors and therefore simply inhibiting the IGF receptor with a relatively high concentration of a kinase inhibitor was not considered adequate specificity data. This limitation was not discussed.

We agree. We have also discussed the limitation of the CaAkt results (Discussion paragraph three). As mentioned above, to further test our idea, we treated zebrafish embryos with free fish and human IGF1. The new data show that adding free IGF1 was sufficient to stimulate NaR cell proliferation under normal calcium conditions (Figure 6F and Figure 6---figure supplement 2). This has provided new and independent evidence supporting our conclusion.

> 5\) There is one experiment wherein a cleavage site mutant of IGFBP-5a was slightly changed in terms of proteolytic degradation in the presence of activated PAPP-aa, but the data are not definitive. It was felt that an experiment showing this mutant could alter the biologic response was required.

We appreciate this comment. We have repeated the proteinase assays and the new results showed that mutation of Igfbp5a K148 to Alanine indeed reduced Papp-aa-mediated proteolysis (Figure 4---figure supplement 1). But the Igfbp5aK148A mutant was also partially degraded, suggesting there may be other proteinases and additional cleavage site(s). This is not unexpected. In addition to PAPP-A and A2, other proteases have been reported to degrade IGFBP-5 in vitro, including thrombin, elastase, cathepsin G, C1s, ADAM 9, ADAM 12s, MMP-1, and MMP-2 etc. (Clemmons, Endocr Rev. 2001, 22:800-17; and Duan and Allard, 2020). Although human PAPP-A-mediated human IGFBP-5 cleavage has been reported and the cleavage site(s) mapped for two decades, to date there is no biological data on any PAPP-A-resistant IGFBP-5 mutants. This is in large part due to the fact that many proteinases can cleave IGFBP-5, depending on different locations/stages, cell types, and physiological/pathological states. In this study, we found that recombinantly expressed Igfbp5a is unstable and susceptible to degradation. Even in the absence of Papp-aa or Papp-ab, it degrades quite rapidly. This is evident in the Mock group shown in Figure 3C, Figure 4A, and Figure 4---figure supplement 1B. Because of this, we were unable to obtain sufficient amount Igfbp5a for biological assays. In the revised manuscript, we have discussed these limitations and the need for further experiments in the future (Discussion paragraphs four, five and six). We have also moved the Igfbp5a and Igfbp5b mutant data into the supplemental materials.

> 6\) There is an extensive paragraph about PAPP-A in the Discussion and an inferential comment to relating to PAPP-aa since it contains the same three modules that are important for PAPP-A activation. However, PAPP-A has different substrates therefore it\'s activity may not be comparable to PAPP-aa. This paragraph should be edited to deemphasize the importance of this possible correlation in light of the limitations already raised.

We agree that there is no experimental evidence showing the three structurally conserved LNR modules in zebrafish Papp-aa play a similar role as those in human PAPP-A. In the revised manuscript, we have shortened and reworded the Discussion about LNR modules (paragraph seven).

> 7\) The model presented in Figure 6F is consistent with the results of the present study, but does not explain a previous study (described in the Introduction), in which deletion of Igfbp5a reduced calcified bone mass, an observation similar to deletion of PAPP-aa (Figure 2G). This previous study also described that deletion of Igfbp5a \"blunted the low \[Ca^2+^\] stress-induced IGF signaling and NaR cell proliferation\". However, at low \[Ca^2+^\], Igfbp5a is being proteolyzed by PAPP-aa, so why would it matter if it is deleted? Deletion of Igfbp5a would be expected to have effects opposite to those of deleting PAPP-aa (which would increase intact Igfbp5a levels). The Discussion states: \"Igfbp5a is critical in activating IGF signaling and promoting adaptive epithelial growth by reactivating NaR cells\" and yet the model in Figure 6F suggests that Igfbp5a maintains quiescence. There should be some acknowledgement/explanation of this contradiction.

Our data and model (Figure 6G) suggest that Papp-aa cleaves Igfbp5a in a \[Ca^2+^\]-dependent manner. Under normal \[Ca^2+^\] conditions, Papp-aa activity is suppressed and Igfbp-5a is intact. Intact Igfbp5a acts as an IGF inhibitory protein as it binds IGF ligands and sequester the IGF ligands from the IGF1 receptor. Under low \[Ca^2+^\] stress, Papp-a activity is increased. This increases IGFBP-5a proteolytic cleavage and releases IGFs from the IGFBP-5a/IGF complex to activate IGF-1 receptor and promotes NaR cells to proliferate. We propose that IGFBP-5 is part of a molecular switch that turns IGF signaling on or off in NaR cells. We have revised the text, Figure 6G and the legends to clearly explain these findings and our model to avoid any confusions.

The results of this study and those of Liu et al., 2018, are in good agreement with each other. In both *papp-aa^-/-^* mutant and *igfbp5a^-/-^* mutant fish, the low \[Ca^2+^\] stress-induced IGF signaling and NaR cell proliferation were blunted.These mutant fish also both suffered from Ca^2+^ and die prematurely, but *papp-aa^-/-^*mutant appeared to be more severe and die younger, indicating that Papp-aa may have substrates other than Igfbp5a. In this study, we have presented data showing that Papp-aa also cleaved Igfbp5b (Figure 4B and Figure 4---figure supplement 1C). We have also added new data comparing *papp-aa^-/-^*mutants and the *papp-aa^-/-^* and *igfbp5a^-/-^* double mutants (see above).

> 8\) There is mention of the rescue of the PAPP-aa mutants with wild-type PAPP-aa, but no mention of whether this rescued the lethal phenotype.

The Tol2 transposon-mediated genetic mosaic assay faithfully target the expression of Papp-aa in a subset of NaR cells in a random fashion. While this approach is very useful in testing the sufficiency of Papp-aa and its mode of action, it cannot rescue the lethality because it only targets the expression of Papp-aa transiently and to a small subset of NaR cells in a mosaic pattern. We have added a sentence in the revised manuscript to make this point clearer (subsection "Endogenous Papp-aa proteinase activity in NaR cells is critical").

> 9\) The impact statement should be reworded, as it is not clear what \"quiescence exit decision\" means without reading the paper.

Following this suggestion, we have re-worded the impact statement.
